These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36498632)

  • 1. Nasal Symptoms in Asthmatic Patients under Treatment with Anti-IL-5 Monoclonal Antibodies. A Real-Life Cohort Study.
    Maza-Solano J; Calvo-Henríquez C; Alobid I; Álvarez-Cendrero M; Palomares Ó; Moreno-Luna R; Santos-Perez J; González-García J; Sánchez-Gómez S
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study.
    Gallo S; Castelnuovo P; Spirito L; Feduzi M; Seccia V; Visca D; Spanevello A; Statuti E; Latorre M; Montuori C; Rizzi A; Boccabella C; Bonini M; De Corso E
    J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study.
    Nolasco S; Crimi C; Pelaia C; Benfante A; Caiaffa MF; Calabrese C; Carpagnano GE; Ciotta D; D'Amato M; Macchia L; Pelaia G; Pellegrino S; Scichilone N; Scioscia G; Spadaro G; Campisi R; Valenti G; Vatrella A; Crimi N
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4371-4380.e4. PubMed ID: 34419679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study.
    Detoraki A; Tremante E; D'Amato M; Calabrese C; Casella C; Maniscalco M; Poto R; Brancaccio R; Boccia M; Martino M; Imperatore C; Spadaro G
    Ther Adv Respir Dis; 2021; 15():17534666211009398. PubMed ID: 33910399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients.
    Bandi F; Gallo S; Preti A; Mozzanica F; Visca D; Marelli M; Maddalone E; Gambarini C; Vaghi A; Spanevello A; Castelnuovo P
    Acta Otorhinolaryngol Ital; 2020 Dec; 40(6):435-443. PubMed ID: 33558772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma.
    Lombardo N; Pelaia C; Ciriolo M; Della Corte M; Piazzetta G; Lobello N; Viola P; Pelaia G
    Int J Immunopathol Pharmacol; 2020; 34():2058738420950851. PubMed ID: 32816558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial.
    Tversky J; Lane AP; Azar A
    Clin Exp Allergy; 2021 Jun; 51(6):836-844. PubMed ID: 33595845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A pilot real-life study.
    Cavaliere C; Segatto M; Ciofalo A; Colizza A; Minni A; Messineo D; Lambiase A; Greco A; de Vincentiis M; Masieri S
    Immunol Lett; 2022 Aug; 248():70-77. PubMed ID: 35752279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study.
    Barroso B; Valverde-Monge M; Alobid I; Olaguibel JM; Rial MJ; Quirce S; Arismendi E; Barranco P; Betancor D; Bobolea I; Cárdaba B; Cruz Carmona MJ; Curto E; Domínguez-Ortega J; González-Barcala FJ; Martínez-Rivera C; Mahíllo-Fernández I; Muñoz X; Picado C; Plaza V; Rodrigo Muñoz JM; Soto-Retes L; Valero A; Del Pozo V; Mullol J; Sastre J
    J Investig Allergol Clin Immunol; 2023 Feb; 33(1):37-44. PubMed ID: 35416154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis.
    Canonica GW; Harrison TW; Chanez P; Menzella F; Louis R; Cosio BG; Lugogo NL; Mohan A; Burden A; Garcia Gil E
    Allergy; 2022 Jan; 77(1):150-161. PubMed ID: 33978983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.
    Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Anti-Interleukin-5 Therapies in Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Wang Q; Sun Q; Chen Q; Li H; Liu D; Wu Q
    Int Arch Allergy Immunol; 2022; 183(7):732-743. PubMed ID: 35108711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-Life Evidence of Mepolizumab Treatment in Chronic Rhinosinusitis with Nasal Polyps: A Multicentric Study.
    Cavaliere C; Loperfido A; Ciofalo A; Di Michele L; Begvarfaj E; Bellocchi G; Bugani M; de Vincentiis M; Greco A; Millarelli S; Plath M; Sculco E; Masieri S
    J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38930104
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-Life Effectiveness of Mepolizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps.
    Domínguez-Sosa MS; Cabrera-Ramírez MS; Marrero-Ramos MDC; Dávila-Quintana D; Cabrera-López C; Carrillo-Díaz T; Del Rosario JJB
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A real world study of anti-IgE monoclonal antibody in the treatment of allergic united airway disease].
    Sui HJ; Zhen Z; Wang QG; Cong TC; Huang JJ; Hu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Feb; 57(2):273-280. PubMed ID: 36797588
    [No Abstract]   [Full Text] [Related]  

  • 17. Real-life effectiveness of biological therapies on symptoms in severe asthma with comorbid CRSwNP.
    Mümmler C; Dünzelmann K; Kneidinger N; Barnikel M; Munker D; Gröger M; Canis M; Behr J; Koch A; Haubner F; Milger K
    Clin Transl Allergy; 2021 Jul; 11(5):e12049. PubMed ID: 34331521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
    Harrison TW; Chanez P; Menzella F; Canonica GW; Louis R; Cosio BG; Lugogo NL; Mohan A; Burden A; McDermott L; Garcia Gil E; Zangrilli JG;
    Lancet Respir Med; 2021 Mar; 9(3):260-274. PubMed ID: 33357499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study.
    Santomasi C; Buonamico E; Dragonieri S; Iannuzzi L; Portacci A; Quaranta N; Carpagnano GE
    Acta Biomed; 2023 Feb; 94(1):e2023028. PubMed ID: 36786266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of reslizumab on the course of chronic rhinosinusitis in patients with eosinophilic asthma].
    Boiko NV; Lodochkina OE; Kit MM; Kuleshova VG; Nedashkovskaya NG
    Vestn Otorinolaringol; 2021; 86(2):43-48. PubMed ID: 33929151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.